AI-generated summary
Forty patients with stable segmental vitiligo on the head or neck were treated with helium-neon laser (632.8 nm) and assessed for repigmentation and blood flow changes. The authors report that marked repigmentation (over 50%) occurred in 60% of patients, and that abnormal blood flow and adrenoceptor responses were normalized after treatment. The study had no control group, and the authors describe their conclusion of effectiveness as based on this uncontrolled design.
- Participants
- 40
- Who or what was studied
- Forty patients with stable-stage segmental vitiligo on the head and/or neck; microcirculatory assessments in six of these patients
- Limits stated in the abstract
- Uncontrolled design with a small microcirculation subgroup of six patients, so the findings cannot establish a causal treatment effect.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Energy density (fluence)
- 3.0 J/cm2
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.